Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP160904.RACgK6he6EG9oR3tCJZCJVunojpMN1z9rRye6586y-XFc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP160904.RACgK6he6EG9oR3tCJZCJVunojpMN1z9rRye6586y-XFc130_assertion type Assertion NP160904.RACgK6he6EG9oR3tCJZCJVunojpMN1z9rRye6586y-XFc130_head.
- NP160904.RACgK6he6EG9oR3tCJZCJVunojpMN1z9rRye6586y-XFc130_assertion wasGeneratedBy ECO_0000203 NP160904.RACgK6he6EG9oR3tCJZCJVunojpMN1z9rRye6586y-XFc130_provenance.
- NP160904.RACgK6he6EG9oR3tCJZCJVunojpMN1z9rRye6586y-XFc130_assertion wasDerivedFrom befree-20140225 NP160904.RACgK6he6EG9oR3tCJZCJVunojpMN1z9rRye6586y-XFc130_provenance.
- NP160904.RACgK6he6EG9oR3tCJZCJVunojpMN1z9rRye6586y-XFc130_assertion SIO_000772 22608605 NP160904.RACgK6he6EG9oR3tCJZCJVunojpMN1z9rRye6586y-XFc130_provenance.
- NP160904.RACgK6he6EG9oR3tCJZCJVunojpMN1z9rRye6586y-XFc130_assertion evidence source_evidence_literature NP160904.RACgK6he6EG9oR3tCJZCJVunojpMN1z9rRye6586y-XFc130_provenance.
- NP160904.RACgK6he6EG9oR3tCJZCJVunojpMN1z9rRye6586y-XFc130_assertion description "[We used gene expression profiling to study the effect of lenalidomide therapy in peripheral blood CD14(+) monocytes of 6 patients with del(5q) and MDS.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP160904.RACgK6he6EG9oR3tCJZCJVunojpMN1z9rRye6586y-XFc130_provenance.